Three years after a dispute erupted over the seizure by EU authorities of Indian-made generics as they were being shipped through Europe, India and the European Commission have struck an interim deal that restricts the 27 member EU states from seizing meds unless there is evidence that drugs will be diverted in the European Union, according to a statement from the Prime Minister’s office in India. The seizures were made after EU authorities in various countries, starting with The Netherlands, maintained the generics violated intellectual property rights and were, therefore, counterfeit. The actions infuriated Indian generic drugmakers, because exporters would be forced to find alternative routes to send shipments, which would increase costs and hurt competitiveness (back story).
